Literature DB >> 35911816

First case of deep neck and descending mediastinal abscess caused by dentoalveolar Eggerthia catenaformis infection.

Stefania Galassi1, Roberto Meranda2, Jacopo Cambi3, Sante De Santis2.   

Abstract

Descending mediastinal abscesses arising from oral (dental or peritonsillar abscess) or deep neck infections (DNIs) often become fatal without surgical drainage. Odontogenic origin was the most common cause of DNIs. We report the first clinical case of a patient with descending mediastinal abscess caused by DNI from Eggerthia catenaformis a Gram-positive anaerobic rod that can be rarely a human pathogen. The patient underwent the extraction of carious molars, cervical and thoracic surgical drainage, and targeted antibiotic therapy with resolution of the infection. Copyright:
© 2022 National Journal of Maxillofacial Surgery.

Entities:  

Keywords:  Anaerobic bacteria; Eggerthia catenaformis; deep neck infection; mediastinitis; odontogenic infection

Year:  2022        PMID: 35911816      PMCID: PMC9326201          DOI: 10.4103/njms.njms_463_21

Source DB:  PubMed          Journal:  Natl J Maxillofac Surg        ISSN: 0975-5950


INTRODUCTION

In 1935, microbiologists isolated a new species of Gram-positive, spore-forming bacteria from human feces called Lactobacillus catenaformis.[1] This bacterium, reclassified as Eggerthia catenaformis in 2011, based on 16S rRNA gene sequencing, was later isolated from intestinal and pleural infections.[2] Recently, a second draft genome sequence of E. catenaformis has shown that this strain can be a human pathogen, and two patients with dental abscesses and one with a lung abscess and pleura empyema have been described.[345] We present an interesting case of DNI and descending mediastinitis complicating an isolated E. catenaformis odontogenic infection and which was successfully treated in our hospital. The patient gave consent for her radiological images and clinical information to be reported in a journal.

CASE REPORT

A 61-year-old immunocompetent Russian woman was admitted to the ENT department for severe right submandibular nonfluctuant swelling and mild trismus. These symptoms were preceded by a 2-week history of infection in the right second and third mandibular molars (4.7 and 4.8 according to the Federation Dentaire Internationale World Dental Federation notation) treated with 6 days of amoxicillin 1 g BID, but with minimal improvement in the clinical picture. Physical examination revealed dental caries in teeth 4.7 and 4.8 and swelling of the mouth floor. Temperature on admission was 39.1°C, total leukocyte count was 18.1 × 106/mL (reference: 3.5–8.5 × 106/mL), and C-reactive protein was 2.19 mg/dL (reference: <0.3 mg/dL). A neck and chest computed tomography (CT) scan with intravenous contrast demonstrated an extensive abscess in the parapharyngeal and neck space on the right side with the left displacement of the larynx and trachea, but without superior mediastinum involvement [Figure 1]. The initial diagnosis was a cervical and mouth abscess with an odontogenic origin.
Figure 1

Computed tomography axial projection of the oropharynx shows an abscess in the right parapharyngeal space

Computed tomography axial projection of the oropharynx shows an abscess in the right parapharyngeal space Acute surgical drainage of a right neck abscess, extraction of carious molars (teeth 4.6, 4.7, and 4.8), and tracheostomy were performed under general anesthesia. The abscess fluid was drained and sent to the microbiology laboratory for culture. At the same time, empirical therapy with intravenous ceftriaxone (1 g BID) and metronidazole (500 mg TID) was initiated. On postoperative day 4, the patient's condition deteriorated with chest pain and tachypnea. An additional CT scan [Figure 2] showed a new abscess in the anterior superior mediastinal space and initial thrombosis of the jugular vein. An urgent right thoracotomy was performed with positioning of a Jackson-Pratt drainage tube.
Figure 2

Chest computed tomography on the 4th day; abscesses were located in the upper mediastinal space and in the right paraesophageal and paratracheal spaces. (a) Coronal projection; (b) Axial projection; (c) Sagittal projection

Chest computed tomography on the 4th day; abscesses were located in the upper mediastinal space and in the right paraesophageal and paratracheal spaces. (a) Coronal projection; (b) Axial projection; (c) Sagittal projection Fluid abscess cultures from the neck and mediastinum revealed the presence of E. catenaformis and Streptococcus constellatus. After determination of the minimum inhibitory concentration [MIC; Table 1], antibiotic therapy was modified with the introduction of clindamycin (900 mg TID) for a total duration of 7 days.
Table 1

Antimicrobial sensitivity with minimum inhibitory concentration

Antimicrobial agent Eggerthia catenaformis Streptococcus constellatus


MIC (µg/mL)InterpretationMIC (µg/mL)Interpretation
Amoxicillin-clavulanate<8Sensitive<8Sensitive
Amoxicillin<4Sensitive<8Sensitive
Clindamycin<0.25Sensitive<0.25Sensitive
Piperacillin/tazobactam<8Sensitive<0.25Sensitive
Benzylpenicillin<0.25Sensitive<1Sensitive
Imipenem<2Sensitive<1Sensitive
Vancomycin<2Sensitive<2Sensitive
Imipenem<2Sensitive<2Sensitive

MIC: Minimum inhibitory concentration

Antimicrobial sensitivity with minimum inhibitory concentration MIC: Minimum inhibitory concentration In the following days, the patient gradually improved [Figure 3], the cervical drainage tube was removed on the 6th day and mediastinal drainage after 7 days. The patient was discharged on the 15th day with normal clinical and laboratory findings. At 3 months of follow-up, the patient had completely recovered.
Figure 3

Neck and chest computed tomography after thoracotomy on the 6th day; (a) Axial projection of head-and-neck with volume reduction of the right laterocervical abscess (b) coronal projection of the chest with mediastinal drainage and the volumetric reduction of the mediastinal abscess

Neck and chest computed tomography after thoracotomy on the 6th day; (a) Axial projection of head-and-neck with volume reduction of the right laterocervical abscess (b) coronal projection of the chest with mediastinal drainage and the volumetric reduction of the mediastinal abscess

DISCUSSION

Descending mediastinal abscesses usually arise from oral (dental or peritonsillar abscess) or neck infections and often become fatal without surgical drainage if the infection and inflammation spread widely in the mediastinum. This disease has become generally uncommon since the introduction of antibiotic therapy decades ago. Early surgical mediastinal drainage is strongly recommended to reduce the risk of mortality.[6] Odontogenic infections are usually localized and remain confined to the oral cavity if treated early with antibiotherapy, dental treatment, extraction, incision, or drainage. However, odontogenic infections traveling through the fascial plane of the neck can spread into the mediastinum. The risk of this increase is in the case of poor oral hygiene, diabetes, or immunodeficiency. Most studies report that men are affected more often by severe odontogenic infections than women.[78] In a recent retrospective analysis, an odontogenic origin was the most common cause of DNIs.[9] Our patient had poor oral hygiene and was malnourished. She had several untreated tooth infections which involved the second and third mandibular molars with apical infection. We hypothesized that the recent low dose amoxicillin treatment may have selected E. catenaformis infection. This may explain the rapid downward spread of the infectious process that had involved a large part of the neck and anterior mediastinum. In accordance with previous studies, we advocate broad-spectrum antibiotics in combination with early and aggressive cervical and superior mediastinal drainage. If the airways are compressed, temporary tracheostomy is the procedure of choice.[10] E. catenaformis, whose natural habitat is human feces, has only recently been associated with infections in humans.[45] In our case, the isolated E. catenaformis strain was multisensitive, but it had a moderately high MIC value for amoxicillin–clavulanate. The best MIC value was for clindamycin and benzylpenicillin.

CONCLUSION

E. catenaformis may cause severe infections in association with other microorganisms. Combined treatment with intravenous antibiotics and surgery was effective. Odontogenic infection should be considered a risk factor for descending mediastinal abscess. Dental practitioners should be aware that early diagnosis and aggressive management are required to reduce the morbidity and mortality of the disease. Despite the high mortality rate associated with this condition, prompt diagnosis, aggressive drainage, removal of the source of infection, and careful postoperative care can save patients with descending mediastinal abscesses. This report also indicates that an accurate and rapid identification of unusual bacterial species can help with faster, more aggressive, and more appropriate antibiotic therapy.

Declaration of patient consent

The authors certify that they have obtained all appropriate patient consent forms. In the form, the patient has given her consent for her images and other clinical information to be reported in the journal. The patient understands that her name and initial will not be published and due efforts will be made to conceal her identity, but anonymity cannot be guaranteed.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  10 in total

1.  The Gram-positive Non-spore-bearing Anaerobic Bacilli of Human Feces.

Authors:  A H Eggerth
Journal:  J Bacteriol       Date:  1935-09       Impact factor: 3.490

2.  First clinical description of Eggerthia catenaformis bacteremia in a patient with dental abscess.

Authors:  Hayarpi H Kordjian; Joyce D J H Schultz; Flemming Schønning Rosenvinge; Jakob Møller; Rune M Pedersen
Journal:  Anaerobe       Date:  2015-07-11       Impact factor: 3.331

3.  Reclassification of Lactobacillus catenaformis (Eggerth 1935) Moore and Holdeman 1970 and Lactobacillus vitulinus Sharpe et al. 1973 as Eggerthia catenaformis gen. nov., comb. nov. and Kandleria vitulina gen. nov., comb. nov., respectively.

Authors:  Elisa Salvetti; Giovanna E Felis; Franco Dellaglio; Anna Castioni; Sandra Torriani; Paul A Lawson
Journal:  Int J Syst Evol Microbiol       Date:  2010-11-26       Impact factor: 2.747

4.  Descending necrotizing mediastinitis: a retrospective surgical experience.

Authors:  L M Sancho; H Minamoto; A Fernandez; L U Sennes; F B Jatene
Journal:  Eur J Cardiothorac Surg       Date:  1999-08       Impact factor: 4.191

Review 5.  Optimal treatment of descending necrotising mediastinitis.

Authors:  M J Corsten; F M Shamji; P F Odell; J A Frederico; G G Laframboise; K R Reid; E Vallieres; F Matzinger
Journal:  Thorax       Date:  1997-08       Impact factor: 9.139

6.  Eggerthia catenaformis bacteremia in a patient with an odontogenic abscess.

Authors:  Carla Foronda; Elizabeth Calatrava; Isabel Casanovas; Lina Martín-Hita; José María Navarro-Marí; Fernando Cobo
Journal:  Anaerobe       Date:  2019-04-17       Impact factor: 3.331

7.  First case of pleural empyema and pulmonary abscess caused by Eggerthia catenaformis.

Authors:  Pauline Duport; Guillaume Miltgen; Clément Kebbabi; Olivier Belmonte; Nathalie Coolen-Allou; Jérôme Allyn; Nicolas Allou
Journal:  Anaerobe       Date:  2018-01-31       Impact factor: 3.331

8.  Management of descending necrotizing mediastinitis.

Authors:  Petros Mihos; Konstantinos Potaris; Ioannis Gakidis; Dimitrios Papadakis; Georgios Rallis
Journal:  J Oral Maxillofac Surg       Date:  2004-08       Impact factor: 1.895

9.  Deep neck infection and descending mediastinitis as lethal complications of dentoalveolar infection: two rare case reports.

Authors:  Bamidele Johnson Alegbeleye
Journal:  J Med Case Rep       Date:  2018-07-07

10.  Deep neck space infections: an upward trend and changing characteristics.

Authors:  Jarno Velhonoja; Meira Lääveri; Tero Soukka; Heikki Irjala; Ilpo Kinnunen
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-12-03       Impact factor: 2.503

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.